Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations

GE. Conway, UK. Shah, S. Llewellyn, T. Cervena, SJ. Evans, AS. Al Ali, GJ. Jenkins, MJD. Clift, SH. Doak

. 2020 ; 35 (4) : 319-330. [pub] 20200912

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
G1000821 Medical Research Council - United Kingdom

Following advancements in the field of genotoxicology, it has become widely accepted that 3D models are not only more physiologically relevant but also have the capacity to elucidate more complex biological processes that standard 2D monocultures are unable to. Whilst 3D liver models have been developed to evaluate the short-term genotoxicity of chemicals, the aim of this study was to develop a 3D model that could be used with the regulatory accepted in vitro micronucleus (MN) following low-dose, longer-term (5 days) exposure to engineered nanomaterials (ENMs). A comparison study was carried out between advanced models generated from two commonly used liver cell lines, namely HepaRG and HepG2, in spheroid format. While both spheroid systems displayed good liver functionality and viability over 14 days, the HepaRG spheroids lacked the capacity to actively proliferate and, therefore, were considered unsuitable for use with the MN assay. This study further demonstrated the efficacy of the in vitro 3D HepG2 model to be used for short-term (24 h) exposures to genotoxic chemicals, aflatoxin B1 (AFB1) and methyl-methanesulfonate (MMS). The 3D HepG2 liver spheroids were shown to be more sensitive to DNA damage induced by AFB1 and MMS when compared to the HepG2 2D monoculture. This 3D model was further developed to allow for longer-term (5 day) ENM exposure. Four days after seeding, HepG2 spheroids were exposed to Zinc Oxide ENM (0-2 µg/ml) for 5 days and assessed using both the cytokinesis-block MN (CBMN) version of the MN assay and the mononuclear MN assay. Following a 5-day exposure, differences in MN frequency were observed between the CBMN and mononuclear MN assay, demonstrating that DNA damage induced within the first few cell cycles is distributed across the mononucleated cell population. Together, this study demonstrates the necessity to adapt the MN assay accordingly, to allow for the accurate assessment of genotoxicity following longer-term, low-dose ENM exposure.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026560
003      
CZ-PrNML
005      
20211026132813.0
007      
ta
008      
211013s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/mutage/geaa018 $2 doi
035    __
$a (PubMed)32780103
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Conway, Gillian E $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
245    10
$a Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations / $c GE. Conway, UK. Shah, S. Llewellyn, T. Cervena, SJ. Evans, AS. Al Ali, GJ. Jenkins, MJD. Clift, SH. Doak
520    9_
$a Following advancements in the field of genotoxicology, it has become widely accepted that 3D models are not only more physiologically relevant but also have the capacity to elucidate more complex biological processes that standard 2D monocultures are unable to. Whilst 3D liver models have been developed to evaluate the short-term genotoxicity of chemicals, the aim of this study was to develop a 3D model that could be used with the regulatory accepted in vitro micronucleus (MN) following low-dose, longer-term (5 days) exposure to engineered nanomaterials (ENMs). A comparison study was carried out between advanced models generated from two commonly used liver cell lines, namely HepaRG and HepG2, in spheroid format. While both spheroid systems displayed good liver functionality and viability over 14 days, the HepaRG spheroids lacked the capacity to actively proliferate and, therefore, were considered unsuitable for use with the MN assay. This study further demonstrated the efficacy of the in vitro 3D HepG2 model to be used for short-term (24 h) exposures to genotoxic chemicals, aflatoxin B1 (AFB1) and methyl-methanesulfonate (MMS). The 3D HepG2 liver spheroids were shown to be more sensitive to DNA damage induced by AFB1 and MMS when compared to the HepG2 2D monoculture. This 3D model was further developed to allow for longer-term (5 day) ENM exposure. Four days after seeding, HepG2 spheroids were exposed to Zinc Oxide ENM (0-2 µg/ml) for 5 days and assessed using both the cytokinesis-block MN (CBMN) version of the MN assay and the mononuclear MN assay. Following a 5-day exposure, differences in MN frequency were observed between the CBMN and mononuclear MN assay, demonstrating that DNA damage induced within the first few cell cycles is distributed across the mononucleated cell population. Together, this study demonstrates the necessity to adapt the MN assay accordingly, to allow for the accurate assessment of genotoxicity following longer-term, low-dose ENM exposure.
650    _2
$a aflatoxin B1 $x toxicita $7 D016604
650    _2
$a buněčné kultury $x metody $7 D018929
650    _2
$a buněčné linie $7 D002460
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a hepatocyty $x účinky léků $7 D022781
650    _2
$a lidé $7 D006801
650    _2
$a játra $x účinky léků $7 D008099
650    _2
$a methylmethansulfonát $x toxicita $7 D008741
650    _2
$a mikrojaderné testy $x metody $7 D015162
650    _2
$a biologické modely $7 D008954
650    _2
$a mutageny $x toxicita $7 D009153
650    12
$a buněčné sféroidy $7 D018874
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Shah, Ume-Kulsoom $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
700    1_
$a Llewellyn, Samantha $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
700    1_
$a Cervena, Tereza $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK $u Department of Nanotoxicology and Molecular Epidemiology, Institute of Experimental Medicine of the CAS, Prague, Czech Republic
700    1_
$a Evans, Stephen J $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
700    1_
$a Al Ali, Abdullah S $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
700    1_
$a Jenkins, Gareth J $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
700    1_
$a Clift, Martin J D $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
700    1_
$a Doak, Shareen H $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
773    0_
$w MED00003429 $t Mutagenesis $x 1464-3804 $g Roč. 35, č. 4 (2020), s. 319-330
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32780103 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132820 $b ABA008
999    __
$a ok $b bmc $g 1715325 $s 1147067
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 35 $c 4 $d 319-330 $e 20200912 $i 1464-3804 $m Mutagenesis $n Mutagenesis $x MED00003429
GRA    __
$a G1000821 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...